Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: BLUEWILLOW BIOLOGICS INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-01 to 2024-08-31
Current total value of award: $3295688
Description: DEVELOPMENT OF NANOVAX TM (OIL IN WATER NANOEMULSION ADJUVANT) FORMULATED ALLERGENS AS INTRANASAL IMMUNOTHERAPEUTIC VACCINES FOR PEANUT ALLERGY. PHASE II.